7-Year-Old Originally Denied Experimental Drug Doing Well

This is an archived article and the information in the article may be outdated. Please look at the time stamp on the story to see when it was last updated.

MEMPHIS, Tenn. (WTVR) – The Fredericksburg parents who fought to have their seven-year-old son treated with an experimental drug say the medicine is working.

Josh Hardy, who has beaten cancer four times, began being treated with Chimerix’s Brincidofovir at St. Jude Children’s Hospital in Memphis last week.

Aimee Hardy, Josh’s mother, said in a blog post that her son is “very close to getting out of the ICU.”

“After 2 doses of the Brincidofovir, the log copies in Josh’s blood went down to 1000. GOD is truly moving mountains in Josh’s life. And we are grateful we are able to be used to bring GOD Glory,” Hardy wrote.

His mother said that Josh is improving because the drug is suppressing the virus, but that he is not out of the woods yet.

“Josh has tremendous tummy pain because his body is not ridding itself of fluid because his kidneys are not functioning…. The kidney function is the last major key for Josh’s full recovery.”

Read why Josh was originally denied the drug HERE.

Notice: you are using an outdated browser. Microsoft does not recommend using IE as your default browser. Some features on this website, like video and images, might not work properly. For the best experience, please upgrade your browser.